AllPennyStocks.com Kroger (KR) Rises Higher Than Market: Key Facts
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Kroger (KR) Rises Higher Than Market: Key Facts

In the latest trading session, Kroger (KR) closed at $57.90, marking a +2.81% move from the previous day. This change outpaced the S&P 500's 0.44% gain on the day. On the other hand, the Dow registered a gain of 0.98%, and the technology-centric Nasdaq increased by 0.44%.

Coming into today, shares of the supermarket chain had gained 1% in the past month. In that same time, the Retail-Wholesale sector gained 1.04%, while the S&P 500 gained 2.81%.

Investors will be eagerly watching for the performance of Kroger in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on September 11, 2026. On that day, Kroger is projected to report earnings of $1.05 per share, which would represent year-over-year growth of 0.96%. Simultaneously, our latest consensus estimate expects the revenue to be $34.78 billion, showing a 2.47% escalation compared to the year-ago quarter.

In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $5.21 per share and a revenue of $151.36 billion, indicating changes of +7.42% and +2.52%, respectively, from the former year.

Any recent changes to analyst estimates for Kroger should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Kroger presently features a Zacks Rank of #3 (Hold).

From a valuation perspective, Kroger is currently exchanging hands at a Forward P/E ratio of 10.81. This signifies a discount in comparison to the average Forward P/E of 14.8 for its industry.

One should further note that KR currently holds a PEG ratio of 1.51. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As the market closed yesterday, the Retail - Supermarkets industry was having an average PEG ratio of 2.02.

The Retail - Supermarkets industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 185, which puts it in the bottom 25% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
The Kroger Co. (KR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Other Penny Stock Movers

65,000 Patients a Year, Zero Approved Drugs, One Phase 3 Trial
$4.5 Million Could Unlock a Major Cannabis Market
Chilean Gold Developer Gains 15% on Final Permit Clearance


Back to Top